These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1777084)

  • 1. Evaluation of clinical efficacy in antiepileptic drug trials.
    Schmidt D
    Epilepsy Res Suppl; 1991; 3():69-77. PubMed ID: 1777084
    [No Abstract]   [Full Text] [Related]  

  • 2. Obstacles encountered in designing antiepileptic drug trials.
    French JA
    Epilepsy Res Suppl; 1993; 10():81-9. PubMed ID: 8251107
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy and safety of new antiepileptic drugs.
    Richens A
    Epilepsy Res Suppl; 1991; 3():89-96. PubMed ID: 1777087
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient recruitment and compliance issues in clinical trials.
    Cramer JA
    Epilepsy Res Suppl; 1993; 10():211-22. PubMed ID: 8251099
    [No Abstract]   [Full Text] [Related]  

  • 5. Protocol design.
    Wilensky AJ
    Epilepsy Res Suppl; 1993; 10():107-13. PubMed ID: 8251086
    [No Abstract]   [Full Text] [Related]  

  • 6. Sources of variability in clinical trials of new drugs for epilepsy.
    Leppik IE
    Epilepsy Res Suppl; 1993; 10():157-66. PubMed ID: 8251091
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of antiepileptic drugs on the natural history of epilepsy.
    Reynolds EH
    Epilepsy Res Suppl; 1991; 3():15-20. PubMed ID: 1777072
    [No Abstract]   [Full Text] [Related]  

  • 8. Study population selection.
    Treiman DM
    Epilepsy Res Suppl; 1993; 10():125-35. PubMed ID: 8251088
    [No Abstract]   [Full Text] [Related]  

  • 9. Methodology of clinical trials on new drugs in epilepsy.
    Morselli PL
    Funct Neurol; 1986; 1(4):503-11. PubMed ID: 3609878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drug status in adult outpatients with mental retardation.
    Singh BK; Towle PO
    Am J Ment Retard; 1993; 98 Suppl():41-6. PubMed ID: 8352921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternate endpoint: EEG assessment of antiepileptic drug efficacy and toxicity.
    Mizrahi EM
    Adv Neurol; 1998; 76():209-21. PubMed ID: 9408479
    [No Abstract]   [Full Text] [Related]  

  • 12. Loreclezole.
    De Beukelaar F; Tritsmans L
    Epilepsy Res Suppl; 1991; 3():125-8. PubMed ID: 1777067
    [No Abstract]   [Full Text] [Related]  

  • 13. Alternative analyses for antiepileptic drug trials.
    Pledger GW; Sahlroot JT
    Epilepsy Res Suppl; 1993; 10():167-74. PubMed ID: 8251092
    [No Abstract]   [Full Text] [Related]  

  • 14. Stiripentol.
    Vincent JC
    Epilepsy Res Suppl; 1991; 3():153-6. PubMed ID: 1777073
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug resistance in epilepsy].
    Rabending G; Scherber A
    Z Arztl Fortbild (Jena); 1990; 84(15):761-6. PubMed ID: 2267815
    [No Abstract]   [Full Text] [Related]  

  • 16. What can we learn from clinical trials of anticonvulsant drugs in epilepsy?
    Perucca E
    Eur J Pain; 2002; 6 Suppl A():35-44. PubMed ID: 11888239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic animal models for generalized non convulsive epilepsies and new antiepileptic drugs.
    Avanzini G; Marescaux C
    Epilepsy Res Suppl; 1991; 3():29-38. PubMed ID: 1777081
    [No Abstract]   [Full Text] [Related]  

  • 18. European investigational antiepilepsy drug trials.
    Sussman NM
    Epilepsy Res Suppl; 1993; 10():149-55. PubMed ID: 8251090
    [No Abstract]   [Full Text] [Related]  

  • 19. Zonisamide.
    Seino M; Miyazaki H; Ito T
    Epilepsy Res Suppl; 1991; 3():169-74. PubMed ID: 1777076
    [No Abstract]   [Full Text] [Related]  

  • 20. Ralitoline.
    Anhut H; Satzinger G; von Hodenberg A
    Epilepsy Res Suppl; 1991; 3():141-5. PubMed ID: 1777070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.